Order Article Reprints

Drakopoulou E, Georgomanoli M, Lederer CW, Panetsos F, Kleanthous M, Voskaridou E, Valakos D, Papanikolaou E, Anagnou NP. The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34⁺ Cells from Sickle Cell Disease Patients. Viruses. 2022; 14(12):2716. https://doi.org/10.3390/v14122716

Drakopoulou, Ekati, Maria Georgomanoli, Carsten W. Lederer, Fottes Panetsos, Marina Kleanthous, Ersi Voskaridou, Dimitrios Valakos, Eleni Papanikolaou, and Nicholas P. Anagnou. 2022. "The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34⁺ Cells from Sickle Cell Disease Patients" Viruses 14, no. 12: 2716. https://doi.org/10.3390/v14122716

Drakopoulou, E., Georgomanoli, M., Lederer, C. W., Panetsos, F., Kleanthous, M., Voskaridou, E., Valakos, D., Papanikolaou, E., & Anagnou, N. P. (2022). The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34⁺ Cells from Sickle Cell Disease Patients. Viruses, 14(12), 2716. https://doi.org/10.3390/v14122716